U.S. Banks Stock News

Bank7 (BSVN) FY 2025 earnings snapshot Bank7 (BSVN) has wrapped up FY 2025 with fourth quarter revenue of US$24.1 million and basic EPS of US$1.14, while trailing 12 month revenue came in at US$95.7 million and EPS at US$4.56. Over the past six quarters, revenue has ranged between US$22.6 million and US$24.9 million per quarter as EPS moved between US$1.10 and US$1.26. This gives you a clear line of sight on how the top line and per share profits have tracked into the latest print. With a net...

General Mills (GIS) has just posted its Q3 2026 numbers, with revenue at US$4.4b and basic EPS of US$0.57, set against a trailing twelve month EPS of US$4.07 on revenue of US$18.4b. Over recent quarters the company has seen revenue move from US$4.8b in Q2 2026 and US$4.5b in Q1 2026 to the latest US$4.4b print, while basic EPS shifted from US$0.77 and US$2.22 in those periods to US$0.57. This sets up a results season where investors are likely to focus squarely on how margins are holding up...

comScore FY 2025 earnings snapshot comScore (SCOR) just closed out FY 2025 with Q4 revenue of US$93.5 million and basic EPS of US$12.77, alongside full year trailing twelve month figures showing revenue of US$357.5 million and a net loss of US$101.8 million. Over recent quarters the company has seen revenue move in a narrow band between US$85.7 million and US$94.9 million per quarter. At the same time, basic EPS has swung from a loss of US$12.79 to a profit of US$12.77. This leaves investors...

Palomar Holdings (NasdaqGS:PLMR) reported strong fourth quarter results, with revenue figures that were materially ahead of earlier analyst expectations. The quarter highlighted performance in the company’s catastrophe insurance focus, an area closely watched by investors given recent weather and loss events. This update reflects current operating momentum for Palomar’s specialty insurance franchise and has not been widely discussed in recent coverage. Palomar focuses on specialty and...

If you are wondering whether Mercury General at around US$87.85 is still offering value or if most of the opportunity has already played out, this overview helps you frame that question clearly. The stock has pulled back with a 0.8% decline over 7 days and a 6.0% decline over 30 days, following very strong returns of 56.5% over 1 year, 216.2% over 3 years and 71.8% over 5 years. Recent attention around the stock has focused on its longer term share price performance and how that compares...

In March 2026, Gambling.com Group reported that fourth-quarter 2025 sales rose to US$46.24 million and full-year 2025 sales reached US$165.45 million, but the company swung to a full-year net loss of US$32.93 million after recording a US$14.01 million impairment on intangible assets. Alongside these results, the company completed a share buyback of 3,960,663 shares for US$35.58 million and issued 2026 revenue guidance of US$170 million to US$180 million, highlighting a growing focus on data...

Protalix BioTherapeutics FY 2025 Earnings Snapshot Protalix BioTherapeutics (PLX) has wrapped up FY 2025 with fourth quarter revenue of US$9.1 million and a basic EPS loss of US$0.07, as investors weigh the latest numbers against the share price of US$2.21. The company has seen quarterly revenue move from US$18.2 million in Q4 2024 to US$10.1 million in Q1 2025, US$15.7 million in Q2 2025, US$17.9 million in Q3 2025 and US$9.1 million in Q4 2025. Basic EPS shifted from US$0.09 in Q4 2024 to...

Yuanbao posted its FY 2025 fourth quarter results with revenue of C¥1.2b and basic EPS of C¥7.49, alongside trailing twelve month EPS of C¥55.72 on revenue of C¥4.4b and net income of C¥2.0b. The company has seen revenue move from C¥888.76m and EPS of C¥11.01 in Q4 2024 to C¥1.2b and C¥7.49 respectively in Q4 2025, set against trailing twelve month earnings growth of 360.7% and an increase in net profit margin from 13.3% to 45.9%. For investors, the latest set of numbers points to a business...

DocuSign (DOCU) has just wrapped up FY 2026 with fourth quarter revenue of US$836.9 million and basic EPS of US$0.45, alongside net income excluding extra items of US$90.3 million, putting fresh numbers on the table for investors tracking its earnings story. Over recent periods the company has seen quarterly revenue move from US$776.3 million in FY 2025 Q4 to US$836.9 million in FY 2026 Q4, while basic EPS over the same two quarters has gone from US$0.41 to US$0.45, and trailing 12 month EPS...

Gossamer Bio (GOSS) has just closed out FY 2025 with fourth quarter revenue of about US$13.8 million and a basic EPS loss of US$0.21, alongside a trailing twelve month EPS loss of US$0.75 on revenue of US$48.5 million. This sets a clear snapshot of where the business stands heading into 2026. Over recent quarters the company has seen revenue move from US$9.4 million in Q4 2024 through US$9.9 million, US$11.5 million and US$13.3 million to US$13.8 million in Q4 2025, while quarterly EPS losses...

Hello Group (NasdaqGS:MOMO) has just wrapped up FY 2025 with fourth quarter revenue of C¥2,575.8 million and basic EPS of C¥1.46, set against a trailing twelve month tally of C¥10.4 billion in revenue and basic EPS of C¥4.84. Over the past six reported quarters, revenue has moved between C¥2,520.8 million and C¥2,674.7 million, while quarterly basic EPS has ranged from a loss of C¥0.84 to a high of C¥2.58. This gives investors a clear view of how earnings have tracked through the year. With...

Spire Global (SPIR) closed out FY 2025 with Q4 revenue of US$15.8 million, a basic EPS loss of US$0.76, and a net loss of US$25.1 million, against a backdrop of trailing 12 month revenue of US$71.6 million and basic EPS of US$1.66. Over recent quarters the company has seen quarterly revenue range from US$23.9 million in Q1 2025 to US$12.7 million in Q3 2025, while quarterly EPS has swung between a US$3.80 profit in Q2 2025 and losses such as US$1.90 in Q4 2024. This sets up a complex picture...

ClearPoint Neuro (CLPT) just posted its FY 2025 numbers with Q4 revenue of US$10.4 million, a basic EPS loss of US$0.27, and trailing twelve month revenue of US$37.0 million alongside a trailing EPS loss of US$0.90. Over recent periods, the company has seen quarterly revenue move from US$7.8 million in Q4 2024 to US$10.4 million in Q4 2025, while quarterly EPS losses shifted from US$0.20 to US$0.27 over the same stretch. For investors, the update sets solid top line progress against ongoing...

Ovid Therapeutics (OVID) closed FY 2025 with fourth quarter revenue of US$0.72 million and basic EPS of US$0.12, alongside trailing twelve month revenue of US$7.25 million and a trailing basic EPS loss of US$0.24. Over the past year, the company has seen quarterly revenue move from US$0.08 million in Q4 2024 to US$6.27 million in Q2 2025 and US$0.72 million in Q4 2025. Basic EPS has ranged from a loss of US$0.20 in Q3 2024 to a loss of US$0.17 in Q3 2025 and a profit of US$0.12 in Q4 2025...

Andersen Group FY 2025 earnings snapshot Andersen Group (ANDG) has just wrapped up FY 2025 with fourth quarter revenue of US$170.3 million, a basic EPS loss of US$0.18, and trailing twelve month revenue of US$838.7 million, alongside a trailing net margin of 6.9% versus 18.5% a year earlier. Over the last six reported quarters, revenue has moved from US$639.1 million on a trailing basis in FY 2023 to US$838.7 million in FY 2025. Quarterly net income has swung between profit and loss as...

Energy Vault Holdings (NRGV) has posted its FY 2025 numbers with fourth quarter revenue of US$153.3 million and a net loss of US$20.7 million, translating to basic EPS of a US$0.12 loss. On a trailing twelve month basis, revenue sits at US$203.7 million with a net loss of US$103.6 million and basic EPS of a US$0.65 loss. The company’s revenue has moved from US$33.5 million in Q4 2024 to US$153.3 million in Q4 2025, with quarterly basic EPS shifting from a US$0.43 loss to a US$0.12 loss over...

Weibo (NasdaqGS:WB) has wrapped up FY 2025 with fourth quarter revenue of US$473.3 million and a small loss, with basic EPS at US$0.02, after earlier quarters in the year posted positive EPS. The company has seen revenue move from US$456.8 million in Q4 2024 to US$473.3 million in Q4 2025. Trailing twelve month EPS sits at US$1.88, which sets up a results season where the focus is firmly on how consistently Weibo can convert its US$1.8 billion of trailing revenue into durable margins. See our...

Lifeway Foods (LWAY) just wrapped up FY 2025 with Q4 revenue of US$55.4 million and basic EPS of US$0.17, capping a year in which trailing twelve month revenue reached US$212.5 million and EPS came in at US$0.91. Over the past few quarters, revenue has moved from US$46.1 million in Q1 2025 to US$57.1 million in Q3 and then US$55.4 million in Q4, while quarterly EPS ranged between US$0.17 and US$0.28. This sets the stage for investors to focus on how margins are holding up through this...

Wondering whether LendingClub's current share price reflects its true worth, or if the market is missing something important about the stock. The share price closed at US$13.32, with recent moves including an 8.7% decline over 7 days, a 14.6% decline over 30 days, a 30.3% decline year to date, a 20.0% gain over 1 year, and a 97.0% gain over 3 years, while sitting 27.5% lower over 5 years. These swings have kept LendingClub on many investors' watchlists, as the stock has moved between periods...

Jabil's Latest Quarterly Snapshot Jabil (JBL) has just posted another quarter of solid scale, with Q1 2026 revenue of about US$8.3b and basic EPS of US$1.36 setting the tone for its latest update. The company has seen revenue move from roughly US$7.0b in Q1 2025 to about US$8.3b in Q1 2026, while basic EPS has shifted from US$0.89 to US$1.36 over the same period. This provides a clear view of how the top and bottom lines are tracking across the year. With that backdrop, the key question for...

Titan America (TTAM) FY 2025 earnings snapshot Titan America (TTAM) has wrapped up FY 2025 with fourth quarter revenue of US$405.7 million and basic EPS of US$0.24, while trailing twelve month revenue came in at about US$1.7 billion and EPS at US$1.01, alongside earnings growth of 11.7% over the last year. The company has seen quarterly revenue move from US$389.8 million in Q4 FY 2024 to US$405.7 million in Q4 FY 2025, with quarterly EPS shifting from US$0.21 to US$0.24 as trailing net income...

Adecoagro (NYSE:AGRO) closed out FY 2025 with Q4 revenue of US$415.9 million and a basic EPS loss of US$0.14, as net income excluding extra items came in at a loss of US$15.4 million. The company has seen quarterly revenue range from US$304.2 million to US$415.9 million over 2025, while EPS has swung between a loss of US$0.18 and a profit of US$0.18, underscoring how sensitive margins remain to operating conditions. See our full analysis for Adecoagro. With the headline numbers set, the next...

Kestra Medical Technologies (KMTS) has just posted its latest quarterly update with Q2 2026 revenue of US$22.6 million and a basic EPS loss of US$0.64, alongside a trailing 12 month EPS loss of US$3.44 on revenue of US$74.3 million that highlights the current earnings profile. The company has seen quarterly revenue move from US$14.7 million in Q2 2025 to US$22.6 million in Q2 2026. Over the same period, quarterly basic EPS losses have shifted from US$1.19 in Q2 2025 to US$0.64 in Q2 2026,...

Abeona Therapeutics (ABEO) closed FY 2025 with Q4 revenue of US$5.4 million and basic EPS of a US$0.37 loss, alongside a net income loss of US$20.5 million. Its trailing twelve month figures show basic EPS of US$1.34 and net income of US$71.2 million on revenue of US$5.8 million. Over recent quarters the company has reported revenue of US$0 in Q3 2025, US$0.4 million in Q2, and US$5.4 million in Q4, with quarterly basic EPS moving from a US$2.07 profit in Q2 to losses of US$0.10 in Q3 and...